GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » Days Sales Outstanding

C4X Discovery Holdings (FRA:C4J) Days Sales Outstanding : 34.46 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings Days Sales Outstanding?

C4X Discovery Holdings's average Accounts Receivable for the six months ended in Jan. 2024 was €5.43 Mil. C4X Discovery Holdings's Revenue for the six months ended in Jan. 2024 was €28.75 Mil. Hence, C4X Discovery Holdings's Days Sales Outstanding for the six months ended in Jan. 2024 was 34.46.

The historical rank and industry rank for C4X Discovery Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:C4J' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.13   Med: 36.35   Max: 272.68
Current: 48.67

During the past 12 years, C4X Discovery Holdings's highest Days Sales Outstanding was 272.68. The lowest was 1.13. And the median was 36.35.

FRA:C4J's Days Sales Outstanding is ranked better than
70.5% of 878 companies
in the Biotechnology industry
Industry Median: 72.84 vs FRA:C4J: 48.67

C4X Discovery Holdings's Days Sales Outstanding declined from Jan. 2023 (173.44) to Jan. 2024 (34.46).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


C4X Discovery Holdings Days Sales Outstanding Historical Data

The historical data trend for C4X Discovery Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings Days Sales Outstanding Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.11 172.12 275.86

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 818.94 107.60 173.44 1,551.25 34.46

Competitive Comparison of C4X Discovery Holdings's Days Sales Outstanding

For the Biotechnology subindustry, C4X Discovery Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's Days Sales Outstanding falls into.



C4X Discovery Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

C4X Discovery Holdings's Days Sales Outstanding for the fiscal year that ended in Jul. 2023 is calculated as

Days Sales Outstanding (A: Jul. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2022 ) + Accounts Receivable (A: Jul. 2023 )) / count ) / Revenue (A: Jul. 2023 )*Days in Period
=( (2.975 + 0.036) / 2 ) / 1.992*365
=1.5055 / 1.992*365
=275.86

C4X Discovery Holdings's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

Days Sales Outstanding (Q: Jan. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jul. 2023 ) + Accounts Receivable (A: Jan. 2024 )) / count ) / Revenue (A: Jan. 2024 )*Days in Period
=( (0.036 + 10.819) / 2 ) / 28.748*365 / 2
=5.4275 / 28.748*365 / 2
=34.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C4X Discovery Holdings  (FRA:C4J) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


C4X Discovery Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
N/A
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines